Search

Cabot Analysts have once again been included in the Money Show’s Top Picks Report, an annual report from some of the brightest analysts on Wall Street. Here’s a selection.

At the end of the year, I like to look back at what worked in small-cap stocks. The exercise is useful for reminding investors what to look out for. I’m also always curious to see what stocks made investors really rich, and which ones caused the tears to flow. Here’s my list of 10 best and worst small caps of 2015.

With plenty of potential potholes threatening the stock market, some defensive stocks make sense. Here’s one defensive small-cap growth stock to consider.

Building an investment portfolio is scary. Here’s what you need to know so you can make money and stop worrying about losing everything.

The most important factor when deciding how to manage a retirement portfolio is where you are in your investing journey. In other words, are you adding or withdrawing?

Want to know the best way to combat a volatile market? Cheap dividend stocks. And these two dividend stalwarts are particularly cheap at the moment.

“Founded in 1937, Baltimore-based T. Rowe Price Group, Inc. (TROW – yield 2.50%) is a global investment management organization with $520.9 billion in assets under management as of June 30, 2011. The organization provides a broad array of mutual funds, subadvisory services and separate account management for individual...

How would you like to own shares in a company that sends you a check every month, regular as Social Security? You can do so, with monthly dividend stocks.

Digital payment companies are benefiting from the rise in non-cash payments. And these two digital payment stocks are already getting a nice boost.

With Japan overheating and China in the doldrums, South Korea may be the Asian investing play for 2024. Here are five ways to play it.

After months of losses, Kimberly-Clark threw a lifeline to struggling Tylenol maker Kenvue by offering to buy the company, but should you buy the stock?

We recently conducted a short survey of our Dick Davis Investment Digest subscribers. Several common concerns were market volatility and economic uncertainty (which I wrote about two weeks ago here). Today, I want to address a third common refrain. As a subscriber from Texas put it: “Maximize dividend income...

Holding a great growth stock forever can be smart. Excellent stock-picking combined with a bull market can be rewarding.

Drug manufacturing is a $160 billion market, with $30 billion in profits. By 2020, sales are expected to top $170 billion. That bodes well for drug stocks.

There’s been a lot of hand-wringing about the havoc last week’s GameStop Affair wrought. I see it in a totally different light.

A continuing rally to start 2023 is largely dependent on the Fed successfully engineering a “soft landing.” Here are two dividend stocks we like in case they don’t.

Enovix (ENVX) Up On Q1 Results and Development Agreement, Weave Communications (WEAV) Dips After Q1 Report